PharmaShots | Incisive News in 3 Shots

Subscribe Now

SERENITY Study

Lilly Presents Results of Mirikizumab in P-II SERENITY Study for Crohn's Disease at DDW 2021

Lilly Presents Results of Mirikizumab in P-II SERENITY Study for Crohn's Disease at DDW 2021

May 24, 2021

Lilly Reports Results of Mirikizumab in P-ll SERENITY Study for Crohn's Disease

Lilly Reports Results of Mirikizumab in P-ll SERENITY Study for Crohn's Disease

October 13, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us